Le Lézard
Classified in: Business, Covid-19 virus
Subject: EXE

USAGov's Tips to Jump-Start Your 2022


WASHINGTON, Jan. 20, 2022 /PRNewswire/ -- As the days unfold into the new year, it can be hard to prioritize the things that need to be done first. From applying for financial help to renewing personal documents, the to-do list can become daunting. If you're unsure of where to begin, USAGov has reminders of what government programs and information to add to the top of your list.

Stay informed with USAGov year round: Visit USA.gov, your official guide to government information and resources. Subscribe to official emails. For quick and timely updates, follow @USAGov on Facebook, Instagram and Twitter.

 

SOURCE USAGov


These press releases may also interest you

at 06:15
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to  ResearchAndMarkets.com's offering. The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Amplitude, Inc. . Shareholders who purchased shares of AMPL during...

at 05:45
The Gross Law Firm issues the following notice to shareholders of Nextdoor Holdings, Inc. f/k/a Khosla Ventures Acquisition Co. II ....

at 05:30
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...



News published on and distributed by: